| Ryan D Morris, DDS | |
|
3950 Veterans Dr Ste 100, Saint Cloud, MN 56303-3424 | |
| (320) 252-3611 | |
| (320) 252-7574 |
| Full Name | Ryan D Morris |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Experience | 18 Years |
| Location | 3950 Veterans Dr Ste 100, Saint Cloud, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326255241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | D12760 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centrasota Oral And Maxillofacial Surgeons Pa | 7315969326 | 6 |
News Archive
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
Kids across the U.S. are getting off the couch and getting their dance on. Following the lead of a successful tournament throughout the state of West Virginia, KONAMI today announced the 2011 DanceDanceRevolution Hawaii State Championship Tournament, designed to promote the importance of exercise and healthy lifestyles for youths all across the Aloha State and nationwide.
At the World Congress of Neurology in Kyoto a group of Indian researchers presented a new 15-minute assessment to monitor dementia patients on an ongoing basis. The reliable telephone interview assessment technique opens up new possibilities for early detection as well as treating and monitoring Alzheimer's patients.
Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study that is researching the use of the first recombinant Factor VIII (rFVIII) derived from a human cell line (Human-cl rhFVIII).
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major player in RNAi industry to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.
› Verified 2 days ago
| Entity Name | Centrasota Oral & Maxillofacial Surgeons Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598710477 PECOS PAC ID: 7315969326 Enrollment ID: O20060110000046 |
News Archive
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
Kids across the U.S. are getting off the couch and getting their dance on. Following the lead of a successful tournament throughout the state of West Virginia, KONAMI today announced the 2011 DanceDanceRevolution Hawaii State Championship Tournament, designed to promote the importance of exercise and healthy lifestyles for youths all across the Aloha State and nationwide.
At the World Congress of Neurology in Kyoto a group of Indian researchers presented a new 15-minute assessment to monitor dementia patients on an ongoing basis. The reliable telephone interview assessment technique opens up new possibilities for early detection as well as treating and monitoring Alzheimer's patients.
Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study that is researching the use of the first recombinant Factor VIII (rFVIII) derived from a human cell line (Human-cl rhFVIII).
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major player in RNAi industry to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan D Morris, DDS 3950 Veterans Dr Ste 100, Saint Cloud, MN 56303-3424 Ph: (320) 252-3611 | Ryan D Morris, DDS 3950 Veterans Dr Ste 100, Saint Cloud, MN 56303-3424 Ph: (320) 252-3611 |
News Archive
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
Kids across the U.S. are getting off the couch and getting their dance on. Following the lead of a successful tournament throughout the state of West Virginia, KONAMI today announced the 2011 DanceDanceRevolution Hawaii State Championship Tournament, designed to promote the importance of exercise and healthy lifestyles for youths all across the Aloha State and nationwide.
At the World Congress of Neurology in Kyoto a group of Indian researchers presented a new 15-minute assessment to monitor dementia patients on an ongoing basis. The reliable telephone interview assessment technique opens up new possibilities for early detection as well as treating and monitoring Alzheimer's patients.
Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study that is researching the use of the first recombinant Factor VIII (rFVIII) derived from a human cell line (Human-cl rhFVIII).
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major player in RNAi industry to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.
› Verified 2 days ago
Donald M. Primley, D.D.S., M.S. Dentist Medicare: Medicare Enrolled Practice Location: 3950 Veterans Dr, Suite 100, Saint Cloud, MN 56303 Phone: 320-252-3611 Fax: 320-252-7574 | |
Dr. Catherine Elaine Wurm, DDS, MS Dentist Medicare: Medicare Enrolled Practice Location: 1521 Northway Dr, Suite 115, Saint Cloud, MN 56303 Phone: 320-656-1456 Fax: 320-656-0195 | |
Dr. Sean Philip Welander, D.D.S. Dentist Medicare: Accepting Medicare Assignments Practice Location: 3950 Veterans Dr Ste 100, Saint Cloud, MN 56303 Phone: 320-252-3611 Fax: 320-252-7574 | |
Rebecca Ann Hanson, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1411 W Saint Germain St, Suite 104, Saint Cloud, MN 56301 Phone: 320-255-1111 Fax: 320-255-1602 | |
Dr. Funsho Afoluke Akinluyi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4128 2nd St S, Saint Cloud, MN 56301 Phone: 320-774-2566 | |
Dr. Aaron Daniel Imdieke, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1201 Maine Prairie Rd, Saint Cloud, MN 56301 Phone: 320-252-6233 Fax: 320-252-9261 | |
Dr. Michael Jerome Schiff, D.D.S. Dentist Medicare: Accepting Medicare Assignments Practice Location: 3950 Veterans Dr, Suite 100, Saint Cloud, MN 56303 Phone: 320-252-3611 Fax: 320-252-7574 |